HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effect of the LDL-/HDL-cholesterol quotient on progression and regression of arteriosclerotic lesions. An analysis of controlled angiographic intervention studies].

Abstract
The importance of hypercholesterolemia for the development of atherosclerotic lesions is undebatable. It is less evident, however, whether the progression of established lesions can be influenced by modifying lipid levels. The review of seven controlled angiographic intervention trials shows that different criteria are used to define progression of lesions. The relation of progression to regression (progression/regression ratio), however, is a useful marker for the activity of coronary artery disease. Patients with familial hypercholesterolemia have a progression/regression ratio of between 3 and 7. There is a consistent relationship between the progression/regression ratio and the LDL-/HDL-cholesterol ratio in both control and intervention groups in these trials. Groups with a LDL-/HDL-cholesterol ratio of 5 have six times more progression than regression. If the LDL-/HDL-cholesterol ratio is less than 2.5 regression occurs more often than progression (i.e. progression/regression ratio less than 1). Thus, in the management of hyperlipidemic patients a LDL-/HDL-cholesterol ratio of less than 2.5 should be achieved if regression of atherosclerotic lesions is desired.
AuthorsH Gohlke
JournalWiener klinische Wochenschrift (Wien Klin Wochenschr) Vol. 104 Issue 11 Pg. 309-13 ( 1992) ISSN: 0043-5325 [Print] Austria
Vernacular TitleDer Einfluss des LDL-/HDL-Cholesterin-Quotienten auf die Progression und Regression von arteriosklerotischen Läsionen. Eine Analyse kontrollierter angiographischer Interventionsstudien.
PMID1621390 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Cholesterol, HDL
  • Cholesterol, LDL
Topics
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Combined Modality Therapy
  • Coronary Artery Disease (blood, therapy)
  • Humans
  • Hyperlipoproteinemia Type II (blood, therapy)
  • Life Style

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: